{"transactions":[{"id":2124181,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":122615,"kind":"person","name":"NIFFENEGGER KATHI","position":1,"cik":"0001620146","reported_name":"NIFFENEGGER KATHI","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2022-11-04T19:27:06.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":4444,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 8,888 Common Shares purchased by the reporting person for $1.1250 per Common Share.  Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date."}],"balance_after":4444,"derivative":{"exercise_price":1,"underlying":"Common Shares","underlying_shares":4444},"source":{"system":"sec-edgar","filing":"0001654954-22-014746","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495422014746/section16.xml","form_type":"4"}},{"id":2124180,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":122615,"kind":"person","name":"NIFFENEGGER KATHI","position":1,"cik":"0001620146","reported_name":"NIFFENEGGER KATHI","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2022-11-04T19:27:06.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":4444,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the \"Initial Exercise Date\") and will expire three years after the Initial Exercise Date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 8,888 Common Shares purchased by the reporting person for $1.1250 per Common Share.  Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the \"Initial Exercise Date\") and will expire three years after the Initial Exercise Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the \"Initial Exercise Date\") and will expire three years after the Initial Exercise Date."}],"balance_after":4444,"derivative":{"exercise_price":1.5,"underlying":"Common Shares","underlying_shares":4444},"source":{"system":"sec-edgar","filing":"0001654954-22-014746","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495422014746/section16.xml","form_type":"4"}},{"id":2124179,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":122615,"kind":"person","name":"NIFFENEGGER KATHI","position":1,"cik":"0001620146","reported_name":"NIFFENEGGER KATHI","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2022-11-04T19:27:06.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":8888,"price":1.125,"value":9999.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 8,888 Common Shares purchased by the reporting person for $1.1250 per Common Share.  Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share."}],"balance_after":10715,"source":{"system":"sec-edgar","filing":"0001654954-22-014746","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495422014746/section16.xml","form_type":"4"}},{"id":2347191,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":122615,"kind":"person","name":"NIFFENEGGER KATHI","position":1,"cik":"0001620146","reported_name":"NIFFENEGGER KATHI","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-08T00:40:13.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":43500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 36 months beginning on the Grant Date."}],"balance_after":43500,"derivative":{"exercise_price":3.71,"expiration_date":"2032-02-28","underlying":"Common Shares","underlying_shares":43500},"source":{"system":"sec-edgar","filing":"0001654954-22-002652","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495422002652/section16.xml","form_type":"4"}},{"id":2739375,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":122615,"kind":"person","name":"NIFFENEGGER KATHI","position":1,"cik":"0001620146","reported_name":"NIFFENEGGER KATHI","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-04-26T21:01:41.000Z","date":"2021-04-22","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 36 months beginning on the Grant Date."}],"balance_after":80000,"derivative":{"exercise_price":5.45,"expiration_date":"2031-04-22","underlying":"Common Shares","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001654954-21-004635","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495421004635/section16.xml","form_type":"4"}},{"id":2987998,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":122615,"kind":"person","name":"NIFFENEGGER KATHI","position":1,"cik":"0001620146","reported_name":"NIFFENEGGER KATHI","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2020-11-09T17:54:56.000Z","date":"2020-11-06","kind":"other","acquired":false,"shares":609,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":0,"derivative":{"exercise_price":4,"exercise_date":"2020-07-08","expiration_date":"2020-11-08","underlying":"Common Shares","underlying_shares":609},"source":{"system":"sec-edgar","filing":"0001654954-20-011986","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420011986/section16.xml","form_type":"4"}},{"id":2987997,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":122615,"kind":"person","name":"NIFFENEGGER KATHI","position":1,"cik":"0001620146","reported_name":"NIFFENEGGER KATHI","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2020-11-09T17:54:56.000Z","date":"2020-11-06","kind":"other","acquired":true,"shares":609,"price":4,"value":2436.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":1827,"source":{"system":"sec-edgar","filing":"0001654954-20-011986","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420011986/section16.xml","form_type":"4"}},{"id":3006842,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":122615,"kind":"person","name":"NIFFENEGGER KATHI","position":1,"cik":"0001620146","reported_name":"NIFFENEGGER KATHI","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2020-10-14T19:51:18.000Z","date":"2020-10-13","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 36 months beginning on the Grant Date."}],"balance_after":50000,"derivative":{"exercise_price":7.44,"expiration_date":"2030-10-13","underlying":"Common shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001654954-20-011140","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420011140/section16.xml","form_type":"4"}},{"id":3269945,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":122615,"kind":"person","name":"NIFFENEGGER KATHI","position":1,"cik":"0001620146","reported_name":"NIFFENEGGER KATHI","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2020-02-14T23:19:22.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":88699,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33% vested on 2/12/2020, with a prorata amount of the balance vesting monthly thereafter over the next 36 months until fully vested"}],"balance_after":88699,"derivative":{"exercise_price":3.16,"expiration_date":"2030-02-12","underlying":"Common Shares","underlying_shares":88699},"source":{"system":"sec-edgar","filing":"0001654954-20-001650","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420001650/section16.xml","form_type":"4"}},{"id":3313132,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":122615,"kind":"person","name":"NIFFENEGGER KATHI","position":1,"cik":"0001620146","reported_name":"NIFFENEGGER KATHI","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2020-01-11T02:36:45.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":609,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable beginning on July 8, 2020 and expire on November 8, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 1,218 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."}],"balance_after":609,"derivative":{"exercise_price":4,"exercise_date":"2020-07-08","expiration_date":"2020-11-08","underlying":"Common Shares","underlying_shares":609},"source":{"system":"sec-edgar","filing":"0001654954-20-000310","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420000310/section16.xml","form_type":"4"}},{"id":3313131,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":122615,"kind":"person","name":"NIFFENEGGER KATHI","position":1,"cik":"0001620146","reported_name":"NIFFENEGGER KATHI","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2020-01-11T02:36:45.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":914,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable beginning on July 8, 2020 and expire on July 8, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 1,218 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."}],"balance_after":914,"derivative":{"exercise_price":4.8,"exercise_date":"2020-07-08","expiration_date":"2023-07-08","underlying":"Common Shares","underlying_shares":914},"source":{"system":"sec-edgar","filing":"0001654954-20-000310","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420000310/section16.xml","form_type":"4"}},{"id":3313130,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":122615,"kind":"person","name":"NIFFENEGGER KATHI","position":1,"cik":"0001620146","reported_name":"NIFFENEGGER KATHI","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2020-01-11T02:36:45.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":1218,"price":4.11,"value":5005.98,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 1,218 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."}],"balance_after":1218,"source":{"system":"sec-edgar","filing":"0001654954-20-000310","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420000310/section16.xml","form_type":"4"}},{"id":3995902,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":122615,"kind":"person","name":"NIFFENEGGER KATHI","position":1,"cik":"0001620146","reported_name":"NIFFENEGGER KATHI","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2018-03-15T00:20:18.000Z","date":"2018-03-12","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option grant under the 2017 Incentive Compensation Plan, which shall vest as to one-third immediately, as to one-third on March 12, 2019 and as to the remaining one-third on September 12, 2019."}],"balance_after":35000,"derivative":{"exercise_price":0.84,"expiration_date":"2025-03-12","underlying":"Common Shares","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001144204-18-014750","document":"tv488519_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000114420418014750/tv488519_4.xml","form_type":"4"}},{"id":4513976,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":122615,"kind":"person","name":"NIFFENEGGER KATHI","position":1,"cik":"0001620146","reported_name":"NIFFENEGGER KATHI","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2016-12-21T22:00:23.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option grant under the 2013 Fixed Share Option Plan, which shall vest as to one-third immediately, as to one-third on December 20, 2017 and as to the remaining one-third on June 20, 2018."}],"balance_after":10000,"derivative":{"exercise_price":2.03,"expiration_date":"2023-12-20","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001144204-16-140709","document":"v455475_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000114420416140709/v455475_4.xml","form_type":"4"}}]}